Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Claudia, Ferrara"'
Publikováno v:
mAbs, Vol 15, Iss 1 (2023)
ABSTRACTThe clinical development of 4–1BB agonists for cancer immunotherapy has raised substantial interest during the past decade. The first generation of 4–1BB agonistic antibodies entering the clinic, urelumab (BMS-663513) and utomilumab (PF-0
Externí odkaz:
https://doaj.org/article/af125b41ea0a475a899cb1f3f84d9370
Autor:
Joana Carla Soares Gonçalves, Roberta Consentino Kronka Mülfarth, Ranny Loureiro Xavier Nascimento Michalski, Alessandra Rodrigues Prata Shimomura, Marcelo de Andrade Roméro, Cristiane Mitiko Sato Furuyama, Johnny Klemke Costa Pinho, Eduardo Gasparelo Lima, Claudia Ferrara Carunchio, Sylvia Tavares Segovia, Karen Daiane dos Santos
Publikováno v:
PARC: Pesquisa em Arquitetura e Construção, Vol 13, Iss 00 (2021)
O edifício da Faculdade de Arquitetura e Urbanismo da Universidade de São Paulo (FAUUSP), na cidade de São Paulo, inaugurado em 1969 e tombado em 1982, é um marco da Escola Paulista de Arquitetura Moderna, expressando uma síntese entre estrutura
Externí odkaz:
https://doaj.org/article/ac4b72b138f8415c9db42bd507feef96
Autor:
Oksana Tyshchuk, Christoph Gstöttner, Dennis Funk, Simone Nicolardi, Stefan Frost, Stefan Klostermann, Tim Becker, Elena Jolkver, Felix Schumacher, Claudia Ferrara Koller, Hans Rainer Völger, Manfred Wuhrer, Patrick Bulau, Michael Mølhøj
Publikováno v:
mAbs, Vol 11, Iss 7, Pp 1219-1232 (2019)
Biotherapeutics may contain a multitude of different post-translational modifications (PTMs) that need to be assessed and possibly monitored and controlled to ensure reproducible product quality. During early development of biotherapeutics, unexpecte
Externí odkaz:
https://doaj.org/article/7a56bb8a59684d8daaabf729937341e7
Autor:
Alfred Zippelius, Petra Herzig, Heinz Läubli, Gieri Cathomas, Christian Klein, Marta Trüb, Franziska Uhlenbrock, Christina Claus, Martin Thelen, Marina Bacac, Maria Amann, Rosemarie Albrecht, Claudia Ferrara-Koller, Daniela Thommen, Sacha Rothschield, Spasenija Savic Prince, Kirsten D Mertz, Robert Rosenberg, Viola Heinzelmann-Schwarz, Mark Wiese, Didier Lardinois, Pablo Umana, Abhishek S Kashyap
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background The costimulatory receptor 4-1BB (CD137, TNFRSF9) plays an important role in sustaining effective T cell immune responses and is investigated as target for cancer therapy. Systemic 4-1BB directed therapies elicit toxicity or low efficacy,
Externí odkaz:
https://doaj.org/article/812e0e185e314e829d4e8fe6aa67b3da
Autor:
Concetta Ingenito, Luciana Buonerba, Claudia Ferrara, Giuseppina Busto, Annamaria Libroia, Gianluca Ragone, Emilio Leo, Beatrice Savastano, Concetta Dello Ioio, Ferdinando De Falco, Simona Iaccarino, Luciano Tarantino, Mario Polverino, Giuseppe Di Lorenzo
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Externí odkaz:
https://doaj.org/article/314d5318bd184facb7adfd75f3f7eb16
Autor:
Kathleen C. Woulfe, Claudia Ferrara, Jose Manuel Pioner, Jennifer H. Mahaffey, Raffaele Coppini, Beatrice Scellini, Cecilia Ferrantini, Nicoletta Piroddi, Chiari Tesi, Corrado Poggesi, Mark Jeong
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 6 (2019)
Myofibril based mechanical studies allow evaluation of sarcomeric protein function. We describe a novel method of obtaining myofibrils from primary cardiomyocyte culture. Adult rat ventricular myocytes (ARVMs) were obtained by enzymatic digestion and
Externí odkaz:
https://doaj.org/article/595589edb5034a48a247cab85f612073
Autor:
Pablo Umaña, Klaus Bosslet, Christian Klein, Suzana Vega-Harring, Gary Xu, Peng Wang, Bin Liu, Cuiying Shao, Hadassah Sade, Werner Scheuer, Frank Herting, Thomas G. Weber, Ekkehard Mössner, Ralf J. Hosse, Sherif Daouti, Ningping Feng, Kathryn Packman, Huifeng Niu, Valeria Runza, Meher Majety, Barbara Weiser, Claudia Ferrara Koller, Inja Waldhauer, Sandra Grau-Richards, Thomas Friess, Katharina Wartha, Peter Brünker
Supplementary information on cell maintenance, and antibody selection and characterization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e363db33bfb70119118f019496cf74f
https://doi.org/10.1158/1535-7163.22507438.v1
https://doi.org/10.1158/1535-7163.22507438.v1
Autor:
Pablo Umaña, Klaus Bosslet, Christian Klein, Suzana Vega-Harring, Gary Xu, Peng Wang, Bin Liu, Cuiying Shao, Hadassah Sade, Werner Scheuer, Frank Herting, Thomas G. Weber, Ekkehard Mössner, Ralf J. Hosse, Sherif Daouti, Ningping Feng, Kathryn Packman, Huifeng Niu, Valeria Runza, Meher Majety, Barbara Weiser, Claudia Ferrara Koller, Inja Waldhauer, Sandra Grau-Richards, Thomas Friess, Katharina Wartha, Peter Brünker
FAP-drozitumab antibody-mediated apoptosis does not correlate with DR5.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3902da6fa0a7fedce1633f385c71997d
https://doi.org/10.1158/1535-7163.22507435.v1
https://doi.org/10.1158/1535-7163.22507435.v1
Autor:
Pablo Umaña, Klaus Bosslet, Christian Klein, Suzana Vega-Harring, Gary Xu, Peng Wang, Bin Liu, Cuiying Shao, Hadassah Sade, Werner Scheuer, Frank Herting, Thomas G. Weber, Ekkehard Mössner, Ralf J. Hosse, Sherif Daouti, Ningping Feng, Kathryn Packman, Huifeng Niu, Valeria Runza, Meher Majety, Barbara Weiser, Claudia Ferrara Koller, Inja Waldhauer, Sandra Grau-Richards, Thomas Friess, Katharina Wartha, Peter Brünker
Characterization and optimization of RG7386 dosing in vivo.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ce9ad07c4aa7036fe31ed07f7a16bea
https://doi.org/10.1158/1535-7163.22507444.v1
https://doi.org/10.1158/1535-7163.22507444.v1
Autor:
Pablo Umaña, Klaus Bosslet, Christian Klein, Suzana Vega-Harring, Gary Xu, Peng Wang, Bin Liu, Cuiying Shao, Hadassah Sade, Werner Scheuer, Frank Herting, Thomas G. Weber, Ekkehard Mössner, Ralf J. Hosse, Sherif Daouti, Ningping Feng, Kathryn Packman, Huifeng Niu, Valeria Runza, Meher Majety, Barbara Weiser, Claudia Ferrara Koller, Inja Waldhauer, Sandra Grau-Richards, Thomas Friess, Katharina Wartha, Peter Brünker
Dysregulated cellular apoptosis and resistance to cell death are hallmarks of neoplastic initiation and disease progression. Therefore, the development of agents that overcome apoptosis dysregulation in tumor cells is an attractive therapeutic approa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::494461f0b5e8179b32511522a796418b
https://doi.org/10.1158/1535-7163.c.6538687.v1
https://doi.org/10.1158/1535-7163.c.6538687.v1